Our first product is an immune-boosting protein to protect Giant Freshwater Prawns against White Tail Disease caused by Machrobrachium rosenbergii nodavirus (MrNV). VakSea’s products are the first immunoprotective products for shrimp. Our products can be delivered orally as part of feed, eliminating the need for expensive, labor intensive, and invasive injection vaccines (when they are even available).
Disease outbreaks cause billions of dollars in losses for the $170 billion aquaculture industry annually, including a $22 billion loss in 2017. VakSea seeks to protect high-value fish and shrimp species from disease. Our initial focus is on the shrimp and prawn aquaculture market in Southeast Asia.
VakSea’s breakthrough technology was developed at the Institute for Marine and Environmental Technology (IMET), part of the University System of Maryland, in the lab of Dr. Vik Vakharia. VakSea has secured exclusive licenses to this technology and is continuing to developing additional intellectual property as we commercialize.